CVS Group plcLSE: CVSG

CVS Group: Total Voting Rights

· Issued by CVS Group plc via RNS

Summary by 6ix AI

CVS Group plc, a UK-listed veterinary group, said that as of October 30, 2026 its total issued share capital consists of 66,725,634 ordinary shares of 0.2p each, following the cancellation of shares it bought back under its share buyback programme.

Key details

  • The buyback programme was announced on May 26, 2026; the cancelled shares are those bought under it before October 30, 2026.
  • Shareholders may use the 66,725,634 figure to work out whether they must report their holding, or a change in it, under the UK Financial Conduct Authority's disclosure and transparency rules.

6ix AI wrote this summary from the release below and checked it against the release.

On 6ix: 6ix.com/news/total-voting-rights-1611

Watch CVS' latest callCVS Group (LSE:CVSG) Q4 2026 Earnings Call · Replay · Sep 24Read the transcript of CVS Group (LSE:CVSG) Q4 2026 Earnings Call
CVS Group plc
30 October 2026
 

30 October 2026

CVS Group plc

("CVS" or the "Company")

Total Voting Rights

CVS, the UK listed veterinary group and a leading provider of veterinary services, announces that, as of 30 October 2026, following cancellation of the Ordinary Shares purchased pursuant to the Company's share buyback programme (announced on 26 May 2026) prior to the date of this announcement, the Company's total issued share capital consists of 66,725,634 ordinary shares of 0.2p each ("Ordinary Shares").

This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules.

Contacts:

CVS Group plc

Scott Morrison, Group General Counsel and Company Secretary

via FGS Global

FGS Global

Faeth Birch

Charlie Chichester

+44 (0)207 251 3801

    [email protected] 

About CVS Group plc (www.cvsukltd.co.uk)

CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange.  CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group operates over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business ("Animed Direct").

The Group employs 9,000 personnel, including 2,500 veterinary surgeons and 3,300 nurses.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

CVS Group plc on 6ix

Story so far

Earlier from CVS

All CVS news releases